Accueil
Détail de l'auteur
Auteur V. DI BEO |
Documents disponibles écrits par cet auteur (7)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
B. ROLLAND ; C. LIONS ; V. DI BEO ; P. CARRIERI ; N. AUTHIER ; T. BARRÉ ; J. DELORME ; P. MATHURIN ; F. BAILLY ; C. PROTOPOPESCU ; F. MARCELLIN |Background: Opioid agonist therapy (OAT) is associated with reduced injection, reduced HCV transmission, and more opportunities to initiate hepatitis C virus (HCV) treatment in people who use drugs (PWUD). We aimed to study the extent to which a[...]Article : Périodique
T. BARRÉ ; E. LAHAIE ; V. DI BEO ; P. CARRIERI ; R. ANDLER ; V. NGUYEN THANH ; F. BECK |INTRODUCTION: Cannabidiol (CBD) is a non-intoxicating cannabis compound found in diverse commercial products worldwide. However, its use may not be fully harmless. Accordingly, it is important to document the prevalence of CBD use and user chara[...]Article : Périodique
Lettre à l'éditeur faisant référence à : Manoharan R., Kemper J., Young J. Exploring the medical cannabis prescribing behaviours of New Zealand physicians. Drug and Alcohol Review, 2022, Vol. 41, n° 6, p. 1355-1366. https://doi.org/10.1111/dar.[...]Article : Périodique
T. ROJAS ROJAS ; V. DI BEO ; J. DELORME ; T. BARRÉ ; P. MATHURIN ; C. PROTOPOPESCU ; F. BAILLY ; M. COSTE ; N. AUTHIER ; M. P. CARRIERI ; B. ROLLAND ; F. MARCELLIN |Background: In the era of direct-acting antivirals (DAA) for the treatment of hepatitis C virus (HCV) infection, HCV treatment uptake remains insufficiently documented in key populations such as people with opioid dependence. Access to opioid ag[...]Article : Périodique
T. BARRÉ ; C. RAMIER ; S. ANTWERPES ; M. COSTA ; M. BUREAU ; G. MARADAN ; V. DI BEO ; C. CUTARELLA ; J. LELOUTRE ; O. RICCOBONO-SOULIER ; S. HEDOIRE ; E. FROT ; F. VERNIER ; S. VASSAS-GOYARD ; S. DUFORT ; C. PROTOPOPESCU ; F. MARCELLIN ; D. CASANOVA ; M. COSTE ; P. CARRIERI |INTRODUCTION: Alcohol use disorder (AUD) is associated with a significant disease burden in France, where alcohol use is deeply rooted in culture. However, the treatment gap is large because of several barriers, including stigmatisation and drin[...]Article : Périodique
T. BARRÉ ; V. DI BEO ; P. ROUX ; A. MOURAD ; P. VERGER ; L. FRESSARD ; T. HERAULT ; J. F. BUYCK ; F. BECK ; P. CARRIERI |Alcohol use is a leading risk factor for premature death and disability. To tackle this issue, more systematic and accurate screening for at-risk consumption is needed in healthcare systems, especially by general practitioners (GPs). We assessed[...]Article : Périodique
T. BARRÉ ; F. MARCELLIN ; V. DI BEO ; J. DELORME ; T. ROJAS ROJAS ; P. MATHURIN ; C. PROTOPOPESCU ; F. BAILLY ; M. COSTE ; N. AUTHIER ; M. P. CARRIERI ; B. ROLLAND |BACKGROUND AND AIMS: Although people who inject drugs (PWID) are the core at-risk population in the hepatitis C virus (HCV) epidemic in industrialized countries, few initiate treatment. Alcohol use disorder (AUD), common within this population, [...]